PP
MRNA icon

PFS Partners’s Moderna MRNA Stock Holding History

PFS Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553 Sell
11
-6
-35% -$280 ﹤0.01% 566
2025
Q4 		$498 Buy
17
+6
+55% +$163 ﹤0.01% 564
2025
Q3 		$282 Hold
11
– – ﹤0.01% 547
2025
Q2 		$301 Hold
11
– – ﹤0.01% 490
2025
Q1 		$309 Hold
11
– – ﹤0.01% 425
2024
Q4 		$453 Hold
11
– – ﹤0.01% 424
2024
Q3 		$728 Sell
11
-21
-66% -$1.93K ﹤0.01% 420
2024
Q2 		$3.8K Hold
32
– – ﹤0.01% 359
2024
Q1 		$3.41K Hold
32
– – ﹤0.01% 384
2023
Q4 		$3.18K Hold
32
– – ﹤0.01% 383
2023
Q3 		$3.31K Hold
32
– – ﹤0.01% 375
2023
Q2 		$3.89K Hold
32
– – ﹤0.01% 382
2023
Q1 		$4.92K Hold
32
– – ﹤0.01% 281
2022
Q4 		$5.75K Buy
+32
New +$5.23K 0.01% 259
2022
Q1 		– Sell
-20
Closed -$5.08K – 360
2021
Q4 		$5.08K Buy
+20
New +$5.85K ﹤0.01% 259

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return